eha 2024 - updates on cll with dr. banerji, dr. assouline, and dr. hillis
Published 3 months ago • 290 plays • Length 46:18Download video MP4
Download video MP3
Similar videos
-
11:55
updates in cll from eha 2024: combinations of btk and bcl2 inhibitors, btk degraders, and more
-
37:22
eha 2024 recap: optimizing the relapsed/refractory cll treatment pathway
-
1:37
the 2024 update to the nccn guidelines for cll/sll: coming soon
-
5:40
recommendations for biomarker analysis in cll: updates from eric 2024
-
16:14
clinical clip from eha 2024
-
46:14
cll: key take-home messages from eha and asco 2024
-
4:13
front-line and r/r updates in cll from eha
-
21:32
precision medicine in chronic lymphocytic leukemia (cll)
-
7:58
positive news & developments when treating chronic lymphocytic leukaemia from the eha
-
1:03
cll trial updates from eha 2022
-
4:34
eha 2024: multiple myeloma roundup
-
1:33
safety and efficacy of zanubrutinib in patients who are intolerant to ibrutinib and/or acalabrutinib
-
1:18
the use of genomics to help select treatment in cll
-
1:43
incidence and risk of secondary malignancy in patients with cll
-
0:52
lessening the economic burden of treating cll
-
11:43
papers unplugged: what's new in the treatment of cll?
-
2:12
is an early diagnosis of cll beneficial in its treatment?
-
45:15
cracking new horizons across all calcium morphologies - aict-asiapcr 2024
-
9:22
papers unplugged: the perspectives of doctors and patients in the treatment of cll